Академический Документы
Профессиональный Документы
Культура Документы
www.elsevier.com/locate/ejim
Original article
Abstract
Background: Spontaneous bacterial peritonitis (SBP), which has been reported to be present in 1030% of patients with cirrhotic ascites, may
easily be overlooked. An important aim of our study was to determine whether there are any clinical signs which, in clinical practice, may
predict or exclude SBP.
Methods: We studied 133 patients with cirrhotic ascites from medical units at nine Swedish university hospitals where there had been at least
one diagnostic ascites tap with analysis of polymorphonuclear leukocytes in the ascites fluid. The patients had initially been questioned about
background factors and physically examined according to a standardized case record form. Samples of blood, urine, and ascites were then
drawn for analysis according to a structured schedule.
Results: SBP could be excluded in 80% of all the cases and was confirmed in 8% of the 133 patients in the final analysis. Abdominal pain
and abdominal tenderness were more common in patients with SBP (p b 0.01), but no other physical sign or laboratory test could separate
SBP cases from the others.
Conclusions: SBP was present in about one-tenth of the hospitalized patients with cirrhotic ascites in this cohort. Performing repeated physical
examinations and paying particular attention to abdominal tenderness may be the best way to become aware of the possible development of this
complication.
2006 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Keywords: Cirrhosis; Diagnosis; Signs; Spontaneous bacterial peritonitis; Symptoms
1. Introduction
Although spontaneous bacterial peritonitis (SBP) is an
important complication of cirrhotic ascites, having been
estimated to be present in 1030% of cases [1], its prevalence
Corresponding author. Tel.: +46 31 3434000; fax: +46 31 259254.
E-mail address: sven.wallerstedt@medic.gu.se (S. Wallerstedt).
0953-6205/$ - see front matter 2006 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
doi:10.1016/j.ejim.2006.07.022
45
Age (years)
Sex [male:female] (n)
SBP
(n = 10)
non-SBP
(n = 123)
61
8:2
58
86:37
Background history
SBP, earlier (n)
Alcohol etiology (n)
Hepatitis C antibodies (n)
Antibiotics due to any infection in
last 6 months (n)
Cortisone treatment (n)
Immunosuppressive treatment (n)
Portosystemic encephalopathy, earlier (n)
Variceal bleeding (n)
Variceal sclerotherapy (n)
0
6
4 (9)
3
9 (119)
84
25 (114)
40 (121)
1
0
2
3
2
7
4 (122)
26
30 (117)
28 (115)
2
1
8
6
2.0 (8)
37
7
36 (121)
61 (121)
4.0 (50)
Physical findings
Body mass index [(weight in kg)/(length in m)2]
ChildPugh-class [A:B:C] (n)
Spiders 3 (n)
Fever (n)
38.0 C (n)
Abdominal tenderness (n)
Portosystemic encephalopathy (n)
25.4 (8)
0:3:7
6
4
1
7
2
23.5 (85)
0:25:98
59 (115)
29 (119)
7
28 (120)
22 (119)
46
Table 2
Laboratory tests (mean values with confidence intervals within parentheses)
in 133 patients with and without SBP
B-hemoglobin (g/L)
B-leukocyte count (109/L)
B-platelet count (109/L)
S-AST (kat/L)
S-ALT (kat/L)
S-alkaline phosphatases (kat/L)
S-bilirubin (mol/L)
Prothrombin complex (INR)
S-sodium (mmol/L)
S-potassium (mmol/L)
S-creatinine (mol/L)
S-albumin (g/L)
S-immunoglobulin G (g/L)
Ascites-volume (L)
Ascites-protein (g/L)
Ascites-albumin (g/L)
Ascites-amylase (kat/L)
U-sodium (mmol/L)
U-potassium (mmol/L)
1
SBP
(n = 10)
non SBP
(n = 123)
116 (102131)
11.5 (5.817.2)
164 (98230)
4.61 (011.06)
1.92 (03.95)
13.3 (3.323.3)
140 (68212)
1.4 (1.191.70)4
132 (128136)
4.2 (3.64.8)
157 (92222)
26 (2231)4
16 (1221)2
5.5 (2.28.9)1
17 (726)2
10 (416)3
0.6 (01.3)1
31 (657)1
37 (1361)1
114 (110117)
10.5 (9.411.7)12
183 (164202)
1.92 (1.562.28)12
1.24 (0.432.04)12
8.8 (7.89.8)12
112 (88136)12
1.5 (1.461.59)12
133 (132134)
4.0 (3.84.1)
124 (106142)12
24 (2325)11
17 (1518)10
6.7 (5.57.9)5
13 (1115)8
8 (510)9
0.6 (0.40.7)6
65 (5476)7
33 (2938)7
11
47